Luis Masana

Reus, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications

Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR).

Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR).

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: May 21, 2026

Lipopotrein(a): from the complex metabolism to the optimal lowering drug.

Lipopotrein(a): from the complex metabolism to the optimal lowering drug.

Journal: Internal and emergency medicine
Published: May 03, 2026

A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention.

A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention.

Journal: The lancet. Diabetes & endocrinology
Published: March 03, 2026

Pilot study evaluating a clinical decision support tool: "Virtual Lipidologist HTE-DLP 3.0".

Pilot study evaluating a clinical decision support tool: "Virtual Lipidologist HTE-DLP 3.0".

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: December 10, 2025

SEA 2026 Standards for Global Control of Vascular Risk.

SEA 2026 Standards for Global Control of Vascular Risk.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: November 28, 2025

Inclisiran for children: is it worth it?

Inclisiran for children: is it worth it?

Journal: The lancet. Diabetes & endocrinology
Published: November 24, 2025

Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit.

Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: October 14, 2025

Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study.

Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study.

Journal: Cardiovascular diabetology
Published: March 25, 2025

Widespread lipoprotein alterations in a REDUCE-IT like population: The icosapent ethyl (IPE)-NMR avatar study.

Widespread lipoprotein alterations in a REDUCE-IT like population: The icosapent ethyl (IPE)-NMR avatar study.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: March 21, 2025

Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach.

Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach.

Journal: European heart journal. Digital health
Published: February 12, 2025

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation.

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation.

Journal: Cardiovascular diabetology
Published: February 08, 2025

Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia.

Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia.

Journal: Heart (British Cardiac Society)
Published: January 18, 2025
Showing 1-12 of 150

Last Updated: 09/26/2026